Skip to main content

Table 4 Cardiometabolic risk profile by categories of diet quality predicted by the Brief Diet Quality Assessment Tool in the predictive validation sample (N = 940)d

From: Development and validation of a Brief Diet Quality Assessment Tool in the French-speaking adults from Quebec

 

Diet quality according to Brief Diet Quality Assessment Tool

All

Women

Men

High (N = 373)

Low (N = 567)

High (N = 227)

Low (N = 251)

High (N = 146)

Low (N = 316)

AHEI score (/110)

71.5 (11.4)

53.1 (11.2)c

72.3 (11.5)

55.2 (10.2)c

70.2 (11.1)

51.4 (11.6)c

Age (years)

46.2 (13.5)

42.5 (13.1)c

45.9 (13.4)

41.7 (13.2)c

46.5 (13.5)

43.1 (13.0)b

BMI (kg/m2)

25.9 (5.2)

28.6 (6.5)c

25.3 (5.2)

28.9 (7.3)c

26.8 (5.1)

28.5 (5.8)b

Waist circumference (cm)

87.3 (14.6)

96.0 (16.6)c

83.0 (13.1)

92.1 (16.7)c

93.9 (14.4)

99.1 (15.8)c

Percent fat (%)

28.9 (9.1)

30.2 (10.4)a

33.0 (7.5)

37.3 (8.7)c

22.6 (7.6)

24.6 (7.9)b

Blood pressure (mmHg)

 Systolic

114.9 (14.6)

119.9 (13.6)c

110.8 (14.2)

115.2 (13.8)c

121.3 (12.6)

123.6 (12.3)

 Diastolic

71.3 (9.9)

75.3 (10.1)c

69.8 (10.0)

74.1 (10.1)c

73.6 (9.3)

76.3 (10.0)b

Lipids (mmol/l)

 TG

1.2 (0.7)

1.5 (1.1)c

1.2 (0.7)

1.4 (1.0)a

1.2 (0.7)

1.5 (1.1)c

 LDL-cholesterol

2.8 (0.9)

2.9 (0.9)

2.8 (1.0)

2.9 (0.9)

2.8 (0.8)

2.9 (0.9)

 HDL-cholesterol

1.5 (0.5)

1.4 (0.4)c

1.6 (0.5)

1.5 (0.4)c

1.4 (0.4)

1.3 (0.4)b

 Chol/HDL-Cholesterol

3.4 (1.1)

3.8 (1.4)c

3.3 (1.2)

3.7 (1.4)b

3.6 (1.1)

4.0 (1.3)b

Glucose (mmol/L)

5.1 (0.7)

5.3 (1.0)a

5.1 (0.7)

5.1 (0.8)

5.3 (0.7)

5.4 (1.3)

Insulin (pmol/L)

88.1 (49.8)

107.0 (77.6)c

86.1 (54.6)

103.6 (60.4)c

91.3 (41.0)

109.7 (88.9)b

  1. Variables are presented as mean (standard deviation)
  2. AHEI Alternate Healthy Eating Index, BMI Body mass index
  3. aP < 0.05, bP < 0.01, cP < 0.001, from the Student’s t-test for the difference between participants classified as having a high diet quality or a low diet quality
  4. dOnly men and women from the development sample among whom cardiometabolic risk factors were measured were included in this analysis. This is why the number of participants (total N = 940) is lower than in the entire development sample (N = 1643)